Table S1. Matched pairs of PRFS-guided (A) vs. T1-magnitude-guided (B) ablative
procedures.
Pairs
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Patient
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
Age (yrs) Target (cm2)
80
4.2x3.0
83
4.5x4.4
61
0.5x0.5
42
0.7x0.5
69
1.2x1.2
70
1.0x1.0
66
3.3x2.5
55
3.1x3.0
72
2.0x1.9
68
2.5x1.8
66
2.8x2.5
66
2.5x.2.7
69
1.2x1.2
76
0.9x0.9
56
1.0x1.0
62
1.5x1.3
66
1.8x1.5
68
1.6x1.5
61
1.3x1.0
51
1.2x1.0
67
1.9x1.8
82
1.7x1.5
67
2.4x2.2
55
2.0x1.8
67
2.8x2.5
82
2.8x2.4
67
2.5x2.0
62
2.5x2.2
61
1.6x1.5
50
2.0x1.8
52
1.4x1.1
64
1.0x1.0
61
2.1x2.0
37
3.1x2.9
68
1.8x1.6
62
2.3x2.0
72
4.4x4.2
66
3.9x3.8
68
0.6x0.6
71
1.3x1.0
69
2.0x1.5
70
2.5x2.3
52
1.5x1.5
62
2.9x2.3
60
1.7x1.5
42
1.2x1.2
61
1.7x1.5
76
1.2x1.2
72
4.0x3.8
51
4.4x4.0
72
2.5x2.1
80
2.5x2.5
58
2.5x2.1
80
2.4x2.2
70
3.8x3.5
66
3.7x3.1
58
1.2x1.0
61
1.9x1.4
57
3.2x3.1
Primary
tumor type
CC
CC
CC
BC
HCC
CC
CC
CC
CC
CC
CC
CC
HCC
HCC
CC
CC
CC
HCC
CC
CC
CC
CC
EC
BC
EC
CC
EC
BC
CC
NPC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
CC
PC
PC
BC
CC
BC
CC
HCC
CC
CC
CC
CC
CC
CC
MM
PC
CC
CC
BC
Localization Applicators
(segment)
(n)
7
2
7
3
7
1
7
1
5
2
7 8
2
8
2
8
2
4
2
4 8
3
6
3
7
2
5
2
7
2
5
2
8 5
2
6
2
7
2
6
2
7
2
8
2
8
1
6
2
6 7
3
6
3
6 7
2
6
2
6
2
6
2
6
2
5 6
1
7
2
2
2
3
3
2
2
3
2
8
4
7
4
4
1
4
2
4
2
8
3
3
1
2 3
2
2
2
6
1
2
1
2
1
8
4
8
2
5
2
5 6
2
2
3
7
2
6 7 8
3
8
2
4
2
8
2
6
3
Applied
energy (kJ)
32
21.2
18.4
22.2
44.1
52.3
37.8
40
41.9
28.8
65.2
33
24.7
34.7
37.7
15.5
24.1
24
37.8
25.7
27.9
25.1
32
44.6
48.1
23
32.4
38
34.8
18
12.2
20.7
32
60.1
32
36
62
65.6
16
30
32
63.8
18
25.1
29.5
20.8
16
16
64.2
32
31.9
25.1
44.3
24.6
48
32
32.1
30.4
36.3
31
32
33
34
B
A
B
A
B
A
B
A
B
60
70
71
67
62
69
65
53
71
3.7x3.1
3.4x3.0
3.2x3.1
5.6x5.0
6.0x3.7
1.9x1.7
1.2x0.8
2.2x1.4
1.4x1.2
NC
CCC
CCC
GC
BC
CC
CC
CC
CC
8
6 7
6
8
2 3
4 8
8
6
7
4
4
1
4
3
2
2
2
2
50.9
64.3
18.8
64.2
69
30.6
35
32
48.2
CC=Colorectal carcinoma, BC=Breast carcinoma, HCC=Hepatocellular carcinoma, EC=Endometrium carcinoma,
NPC=Nasopharyngeal carcinoma, PC= Pancreatic carcinoma, NC=Neuroendocrine carcinoma,
MM=Malignant melanoma, CCC=Cholangiocellular carcinoma